Ali Behbahani - 30 May 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Director
Signature: /s/ Nicole Hatcher, attorney in fact
Issuer symbol: CRSP
Transactions as of: 30 May 2024
Net transactions value: $0
Form type: 4
Filing time: 31 May 2024, 16:50:04 UTC
Previous filing: 06 Jun 2024
Next filing: 07 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Stock Option (Right to buy)	Award	$0	+13,000		$0.000000	13,000	30 May 2024	Common Shares	13,000	$54.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on May 31, 2024 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders.

Content

Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on May 31, 2024 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders.